Terug
Dagbereik
€ 34,85
€ 38,91
52-Weeksbereik
€ 6,42
€ 39,15
Volume
959.958
50D / 200D Gem.
€ 32,17
/
€ 19,01
Vorige Slotkoers
€ 37,15
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -16,4 | 0,4 |
| P/B | 7,6 | 2,9 |
| ROE % | -39,8 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Belangrijkste Punten
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -95,28M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-39,83%
ROIC-37,58%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,02
Current Ratio14,67
Interest Coverage0,00
Waardering
P/E Ratio
-16,35
P/B Ratio7,57
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -119,95M |
| ROE | -39,83% | ROA | -42,44% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -95,28M |
| ROIC | -37,58% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 14,67 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -16,35 | P/B Ratio | 7,57 |
| P/S Ratio | N/A | PEG Ratio | -0,39 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,96B | Enterprise Value | 1,89B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -119,95M | -86,48M | -69,13M | -55,33M | -26,29M |
| EPS (Diluted) | -2,01 | -1,51 | -1,62 | -1,23 | -0,63 |
| Gross Profit | -546.000,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -132,76M | -104,18M | -79,95M | -58,93M | -26,29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 282,61M | 363,56M | 225,86M | 266,18M | 306,70M |
| Total Liabilities | 23,43M | 20,41M | 21,60M | 8,35M | 4,96M |
| Shareholders' Equity | 259,18M | 343,15M | 204,26M | 257,83M | 301,74M |
| Total Debt | 5,81M | 6,22M | 6,50M | 2,62M | 1,18M |
| Cash & Equivalents | 77,39M | 91,97M | 58,01M | 251,21M | 302,18M |
| Current Assets | 265,45M | 347,46M | 211,67M | 257,29M | 304,06M |
| Current Liabilities | 18,09M | 14,59M | 15,33M | 5,70M | 3,62M |